← Leaderboards
Philip T Diaz
Ohio State University
$10,243,656
Attributed
$11,508,312
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2005–19$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$11,508,312 · 7
By mechanism
R01$9,058,128 · 4
N01$2,180,184 · 2
R21$270,000 · 1
Top collaborators
- Serge P Nana-Sinkam5 shared
Most similar at Ohio State University
Same institution · by research overlap
- Ming You$26,875,453
- Philip Diaz$871,787
- Rama K Mallampalli$45,256,042
- Sarah H Tannehill-Gregg$548,500
- Michelle J. Naughton$4,623,136
Others in their field
Top investigators on “Chronic Obstructive Airway Disease”
- James D Crapo · University Of Colorado Denver$90,851,150
- Edwin K Silverman · Brigham And Women'S Hospital$66,435,690
- Prescott G Woodruff · University Of California San Francisco$44,725,610
- Bryan O Buchholz · University Of Massachusetts Lowell$40,621,016
- David D. McManus · Univ Of Massachusetts Med Sch Worcester$40,621,016
- Jane Wilkinson · Broad Institute, Inc.$38,181,500
Research focus
Chronic Obstructive Airway DiseaseLungSmokerInsightCigarette SmokePredispositionPulmonary EmphysemaGeneral PopulationSmokingPhysiologicalResearch PersonnelHigh PrevalencePrevalencePatternAgingPersonsLightLung DiseasesBurden Of IllnessCigarette SmokingAdverse EffectsNatural HistoryProteomeBiology
Grant awards (24)
Accelerated emphysema in HIV-infected smokers: the role of extracellular vesicles$495,822
R01 · FY2019 · DA · contact PI
Accelerated emphysema in HIV-infected smokers: the role of extracellular vesicles$503,540
R01 · FY2018 · DA · contact PI
Accelerated emphysema in HIV-infected smokers: the role of extracellular vesicles$516,715
R01 · FY2017 · DA · contact PI
Accelerated emphysema in HIV-infected smokers: the role of extracellular vesicles$500,087
R01 · FY2016 · DA · contact PI
Accelerated emphysema in HIV-infected smokers: the role of extracellular vesicles$513,148
R01 · FY2015 · DA · contact PI
Title: Long-Term Oxygen Treatment Trial (LOTT) - Regional Clinical Center$209,214
N01 · FY2015 · HL · contact PI
Title: Long-Term Oxygen Treatment Trial (LOTT) - Regional Clinical Center$606,713
N01 · FY2013 · HL · contact PI
Long-term Oxygen Treatment Trial$621,415
N01 · FY2012 · HL · contact PI
Smoking cessation and the natural history of HIV-associated emphysema$799,819
R01 · FY2011 · HL · contact PI
Long-term Oxygen Treatment Trial$621,415
N01 · FY2011 · HL · contact PI
Smoking cessation and the natural history of HIV-associated emphysema$793,917
R01 · FY2010 · HL · contact PI
Smoking cessation and the natural history of HIV-associated emphysema$776,486
R01 · FY2009 · HL · contact PI
Alveolar macrophage proteomics in HIV-induced emphysema$389,820
R01 · FY2009 · HL · contact PI
Green Tea Anticancer Mechanisms in Smokers$135,000
R21 · FY2009 · CA · contact PI
Smoking cessation and the natural history of HIV-associated emphysema$739,322
R01 · FY2008 · HL · contact PI
Alveolar macrophage proteomics in HIV-induced emphysema$389,820
R01 · FY2008 · HL · contact PI
Green Tea Anticancer Mechanisms in Smokers$135,000
R21 · FY2008 · CA · contact PI
Smoking cessation and the natural history of HIV-associated emphysema$774,036
R01 · FY2007 · HL · contact PI
Alveolar macrophage proteomics in HIV-induced emphysema$389,820
R01 · FY2007 · HL · contact PI
Alveolar macrophage proteomics in HIV-induced emphysema$401,463
R01 · FY2006 · HL · contact PI
Alveolar macrophage proteomics in HIV-induced emphysema$411,125
R01 · FY2005 · HL
T-Lymphocytes, Latent Virus and Emphysema Pathogenesis$331,875
R01 · FY2003 · HL
T-Lymphocytes, Latent Virus and Emphysema Pathogenesis$331,313
R01 · FY2002 · HL
LUNG VOLUME REDUCTION SURGERY--CLINICAL CENTER$121,427
N01 · FY2000 · HR